Safety study of RS-C1001 in healthy Chinese adults
Part of Hormones & metabolism clinical trials.
This study tests a new medication called RS-C1001 in healthy Chinese volunteers to see if it's safe and how the body processes it. The drug may help lower cholesterol, but the main goal here is to check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy and between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26, and you weigh at least 110 pounds (if male) or 99 pounds (if female).
- Your LDL cholesterol is below 159 mg/dL and your triglycerides are below 301 mg/dL.
- You do not smoke more than 5 cigarettes per day and can avoid all smoking during the study.
- You agree to use effective birth control (if female) or have your partner use birth control (if male) for 6 months after the last dose.
- You are not taking any prescription or over-the-counter medications, supplements, or herbal products unless approved by the study doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol
This study tests a new medicine called HS-10582 to see if it is safe and how well it works in people with mildly high LDL cholesterol (the 'bad' cholesterol). It may help lower cholesterol levels and could be a future treatment option.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.
This trial compares two very low LDL-cholesterol targets (below 1.0 vs 1.0-1.39 mmol/L) using extra medications (PCSK9 inhibitors) to see which is safer and better for people at extremely high risk of heart attacks or strokes.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.